Calumet generated Q4 2025 sales of 1038600000 and reported a net loss of 37300000. Adjusted EBITDA was 48400000, while Adjusted EBITDA with Tax Attributes improved to 69300000 compared to the prior year period.

Calumet delivered a profitable Q3 2025 with $313.4 million in net income, aided by record margins in Specialty Products & Solutions and ongoing cost reduction efforts.